Yahoo

3 Reasons CWK is Risky and 1 Stock to Buy Instead

Trade CWK on Coinbase
CWK Cover Image
3 Reasons CWK is Risky and 1 Stock to Buy Instead

Cushman & Wakefield currently trades at $13.03 per share and has shown little upside over the past six months, posting a small loss of 2.6%. The stock also fell short of the S&P 500's 12% gain during that period.

Is there a buying opportunity in Cushman & Wakefield, or does it present a risk to your portfolio? Check out our in-depth research report to see what our analysts have to say, it's free .

Why Do We Think Cushman & Wakefield Will Underperform?

We don't have much confidence in Cushman & Wakefield. Here are three reasons why there are better opportunities than CWK, plus one stock we'd rather own.

1. Long-Term Revenue Growth Disappoints

Reviewing a company's long-term sales performance reveals insights into its quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul. Over the last five years, Cushman & Wakefield grew its sales at a weak 5.2% compounded annual growth rate. This was below our standard for the consumer discretionary sector.

Cushman & Wakefield Quarterly Revenue
Cushman & Wakefield Quarterly Revenue

2. Mediocre Free Cash Flow Margin Limits Reinvestment Potential

If you've followed StockStory for a while, you know we emphasize free cash flow. Why, you ask? We believe that in the end, cash is king, and you can't use accounting profits to pay the bills.

Cushman & Wakefield has shown poor cash profitability relative to peers over the last two years, giving the company fewer opportunities to return capital to shareholders. Its free cash flow margin averaged 1.5%, below what we'd expect for a consumer discretionary business.

Cushman & Wakefield Trailing 12-Month Free Cash Flow Margin
Cushman & Wakefield Trailing 12-Month Free Cash Flow Margin

3. New Investments Aren't Moving the Needle

We like to invest in businesses with high returns, but the trend in a company's ROIC can also be an early indicator of future business quality.

Unfortunately, Cushman & Wakefield's ROIC has stayed the same over the last few years. If the company wants to become an investable business, it must improve its returns by generating more profitable growth.

Cushman & Wakefield Trailing 12-Month Return On Invested Capital
Cushman & Wakefield Trailing 12-Month Return On Invested Capital

Final Judgment

Cushman & Wakefield doesn't pass our quality test. With its shares underperforming the market lately, the stock trades at 8.7× forward P/E (or $13.03 per share). While this valuation is optically cheap, the potential downside is huge given its shaky fundamentals. There are better investments elsewhere. Let us point you toward a dominant aerospace business that has perfected its M&A strategy .

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 5 Growth Stocks.The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it's flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE .

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today .

Mobilize your Website
View Site in Mobile | Classic
Share by: